Stryker Corporation, together with its subsidiaries, operates as a medical technology company. It operates through three segments: Orthopaedics; MedSurg; and Neurotechnology and Spine. The Orthopaedics segment offers implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment provides surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, and reprocessed and remanufactured medical devices, as well as other medical devices for use in various medical specialties. The Neurotechnology and Spine segment offers neurosurgical and neurovascular devices that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products, which consists of cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company markets and sells its products to doctors, hospitals, and other healthcare facilities through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors in approximately 100 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Business Analysis of Stryker
The Life Sciences Sector is witnessing a major shakeup, new age business models in the industry are transforming both customers and businesses. Faced with this uncertainity, companies are investing resources to transform their business. An in-depth business analysis is a valuable resource to identify and articulate the need for a business model change. At R&P Research we believe, the starting point for a business analysis is Benchmarking. Business benchmarking can be done at various levels: 1) Industry Benchmarking 2) Peer Benchmarking 3) Disruptors Benchmarking. In this report, we share the snapshot of how Stryker compares against the industry on the major performance indicators. This analysis, along with peer group/disruptors benchmarking and revenue model understanding can help identify growth and cost optimization opportunities to maximize the value delivered by Stryker to its stakeholders. R&P Research Industry Intelligence Platform provides historical data for last 15 years with an easy to use benchmarking interface for an in-depth comparative business analysis.
Here is the performance snapshot of Stryker with an interactive chart.
- Revenue Growth: Stryker reported a revenue growth of 13.9% year-on-year during 2016. Medical Devices Industry grew at 20.5% in the same period
- COGS share of Revenues: As a percentage of revenue, Stryker spent 33.8% of its total revenues on COGS. Medical Devices industry average (COGS share of revenue) in the same period was 41.0%
- R&D share of Revenues: As a percentage of revenue, Stryker spent 6.3% of its total revenues on R&D. Medical Devices industry average R&D spending in the same period was 7.2%
- SG&A share of Revenues: As a percentage of revenue, Stryker spent 36.5% of its total revenues on Sales, Marketing, and General Administration (SG&A). Medical Devices industry average SG&A spending in the same period was 33.2%
- Inventory share of Revenues: As a percentage of revenue, Stryker spent 17.9% of its total revenues on Inventories. Medical Devices industry average Inventory spending in the same period was 14.8%
- Accounts Payable share of Revenues: As a percentage of revenue, Stryker invested 5.3% of its total revenues on Accounts Payable (A/P) Medical Devices industry average Accounts Payable investment in the same period was 9.1%
- Accounts Receivable share of Revenues: As a percentage of revenue, Stryker invested 17.4% of its total revenues on Accounts Receivable (A/R). Medical Devices industry average Accounts Receivable investment in the same period was 17.3%
- PP&E share of Revenues: As a percentage of revenue, Stryker invested 13.9% of its total revenues on Property, Plants, and Equipments (PP&E). Medical Devices industry average PPE investment in the same period was 22.2%
- Intangibles share of Revenues: As a percentage of revenue, Stryker invested 87.1% of its total revenues on Intangibles. Medical Devices industry average Intangibles investment in the same period was 124.7%
- Net Margins: Stryker Net Margins in the year 2016 were 14.5%. Medical Devices industry average Net Margins in the same period were 11.7%
Sector and Industry Association of Stryker
For the purpose of performance benchmarking of a company with a sector or industry average, R&P Research associates every company with one sector and one industry. An industry consists of companies with related/similar business models. A sector comprises of a group of related/similar industries. For high-level analysis purposes, related/similar sectors are grouped into sector groups.
Stryker is associated with Healthcare Sector Group, Life Sciences Sector, and Medical Devices Industry.
Life Sciences sector is comprised of the following industries: Pharmaceuticals; Medical Devices; Biotechnology; Diagnostics & Scientific Instruments. The definitions for each of the industries is as follows:
- Pharmaceuticals industry includes companies that discover, develop, manufacture, and market medicines licensed for use as medications. In general these companies offer pharmaceutical products that can be described as prescription or over-the-counter medicines. Many Pharmaceutical companies also offer a diverse portfolio of animal health products, services and solutions. Many diversified pharmaceutical companies operate in more than two operating segments like consumer health products, medical devices and pharmaceutical.
- Medical Devices industry includes manufacturers and distributors of medical equipments and medical supplies. Medical equipments include large scale capital equipmets such as X-Ray machines and MRI scanners and other nondisposable medical devices like stents and pacemakers. Medical supplies include makers of contact lenses, eyeglass lenses, bandages and other disposable products.
- Biotechnology industry includes Biotechnology product companies, subscription companies, and service companies. Biotechnology product companies offer pharmaceutical drug products that are manufactured in, extracted from, or semi synthesized from biological sources. Subscription-based companies develop genome databases, which can be used to develop medicinal drugs. Service companies offer solutions based on a common technology or generic tool of other large pharmaceutical or biopharmaceutical companies.
- Diagnostics & Scientific Instruments industry includes companies that provide testing products, diagnostic reagents, instruments and diagnostic services to aid in the detection and treatment of a wide range of diseases. It also includes molecular diagnostic and genetic testing companies that develop, manufacture, market and provide diagnostic tests, diagnostic systems and related products and services. Also included are companies that manufacture and market analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics.
Industry Ranking of Stryker
With $11.3 billion revenues, Stryker ranked number 3 of all the companies in the US Medical Devices industry. There were a total of 81 public companies in the US Medical Devices industry that had revenues greater than $50 million during 2016.
The top-10 companies in the US Medical Devices industry by revenues during 2016 were:
- Medtronic ($28.8 billion)
- Becton Dickinson ($12.5 billion)
- Stryker ($11.3 billion)
- Baxter International ($10.2 billion)
- Boston Scientific ($8.4 billion)
- Zimmer Biomet ($7.7 billion)
- Dentsply Sirona ($3.7 billion)
- C. R. Brad ($3.7 billion)
- Varian Medical Systems ($3.2 billion)
- Edwards Lifesciences ($3 billion)
Business Model Analysis (BMA) Framework
We use the following framework to assess the business model of a company. Business Model Analysis framework can be used by organizations to articulate growth strategies and identify cost optimization opportunities. Technology and consulting companies can use this framework to identify the value drivers and pain points of their targeted customers. Entrepreneurs can use this framework to understand the language of business and identify promising business opportunities. This framework can be used by any professional aspiring to take up a leadership role to better understand the businesses challenges, articulate growth strategy, and monitor the business improvement requirements for the organization.